author_facet Livingstone, Katherine M.
Lovegrove, Julie A.
Givens, D. Ian
Livingstone, Katherine M.
Lovegrove, Julie A.
Givens, D. Ian
author Livingstone, Katherine M.
Lovegrove, Julie A.
Givens, D. Ian
spellingShingle Livingstone, Katherine M.
Lovegrove, Julie A.
Givens, D. Ian
Nutrition Research Reviews
The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
Nutrition and Dietetics
Medicine (miscellaneous)
author_sort livingstone, katherine m.
spelling Livingstone, Katherine M. Lovegrove, Julie A. Givens, D. Ian 0954-4224 1475-2700 Cambridge University Press (CUP) Nutrition and Dietetics Medicine (miscellaneous) http://dx.doi.org/10.1017/s095442241200011x <jats:p>With the substantial economic and social burden of CVD, the need to modify diet and lifestyle factors to reduce risk has become increasingly important. Milk and dairy products, being one of the main contributors to SFA intake in the UK, are a potential target for dietary SFA reduction. Supplementation of the dairy cow's diet with a source of MUFA or PUFA may have beneficial effects on consumers' CVD risk by partially replacing milk SFA, thus reducing entry of SFA into the food chain. A total of nine chronic human intervention studies have used dairy products, modified through bovine feeding, to establish their effect on CVD risk markers. Of these studies, the majority utilised modified butter as their primary test product and used changes in blood cholesterol concentrations as their main risk marker. Of the eight studies that measured blood cholesterol, four reported a significant reduction in total and LDL-cholesterol (LDL-C) following chronic consumption of modified milk and dairy products. Data from one study suggested that a significant reduction in LDL-C could be achieved in both the healthy and hypercholesterolaemic population. Thus, evidence from these studies suggests that consumption of milk and dairy products with modified fatty acid composition, compared with milk and dairy products of typical milk fat composition, may be beneficial to CVD risk in healthy and hypercholesterolaemic individuals. However, current evidence is insufficient and further work is needed to investigate the complex role of milk and cheese in CVD risk and explore the use of novel markers of CVD risk.</jats:p> The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies Nutrition Research Reviews
doi_str_mv 10.1017/s095442241200011x
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9zMDk1NDQyMjQxMjAwMDExeA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9zMDk1NDQyMjQxMjAwMDExeA
institution DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
imprint Cambridge University Press (CUP), 2012
imprint_str_mv Cambridge University Press (CUP), 2012
issn 0954-4224
1475-2700
issn_str_mv 0954-4224
1475-2700
language English
mega_collection Cambridge University Press (CUP) (CrossRef)
match_str livingstone2012theimpactofsubstitutingsfaindairyproductswithmufaorpufaoncvdriskevidencefromhumaninterventionstudies
publishDateSort 2012
publisher Cambridge University Press (CUP)
recordtype ai
record_format ai
series Nutrition Research Reviews
source_id 49
title The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_unstemmed The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_full The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_fullStr The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_full_unstemmed The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_short The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_sort the impact of substituting sfa in dairy products with mufa or pufa on cvd risk: evidence from human intervention studies
topic Nutrition and Dietetics
Medicine (miscellaneous)
url http://dx.doi.org/10.1017/s095442241200011x
publishDate 2012
physical 193-206
description <jats:p>With the substantial economic and social burden of CVD, the need to modify diet and lifestyle factors to reduce risk has become increasingly important. Milk and dairy products, being one of the main contributors to SFA intake in the UK, are a potential target for dietary SFA reduction. Supplementation of the dairy cow's diet with a source of MUFA or PUFA may have beneficial effects on consumers' CVD risk by partially replacing milk SFA, thus reducing entry of SFA into the food chain. A total of nine chronic human intervention studies have used dairy products, modified through bovine feeding, to establish their effect on CVD risk markers. Of these studies, the majority utilised modified butter as their primary test product and used changes in blood cholesterol concentrations as their main risk marker. Of the eight studies that measured blood cholesterol, four reported a significant reduction in total and LDL-cholesterol (LDL-C) following chronic consumption of modified milk and dairy products. Data from one study suggested that a significant reduction in LDL-C could be achieved in both the healthy and hypercholesterolaemic population. Thus, evidence from these studies suggests that consumption of milk and dairy products with modified fatty acid composition, compared with milk and dairy products of typical milk fat composition, may be beneficial to CVD risk in healthy and hypercholesterolaemic individuals. However, current evidence is insufficient and further work is needed to investigate the complex role of milk and cheese in CVD risk and explore the use of novel markers of CVD risk.</jats:p>
container_issue 2
container_start_page 193
container_title Nutrition Research Reviews
container_volume 25
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344662359408645
geogr_code not assigned
last_indexed 2024-03-01T17:10:28.961Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=The+impact+of+substituting+SFA+in+dairy+products+with+MUFA+or+PUFA+on+CVD+risk%3A+evidence+from+human+intervention+studies&rft.date=2012-12-01&genre=article&issn=1475-2700&volume=25&issue=2&spage=193&epage=206&pages=193-206&jtitle=Nutrition+Research+Reviews&atitle=The+impact+of+substituting+SFA+in+dairy+products+with+MUFA+or+PUFA+on+CVD+risk%3A+evidence+from+human+intervention+studies&aulast=Givens&aufirst=D.+Ian&rft_id=info%3Adoi%2F10.1017%2Fs095442241200011x&rft.language%5B0%5D=eng
SOLR
_version_ 1792344662359408645
author Livingstone, Katherine M., Lovegrove, Julie A., Givens, D. Ian
author_facet Livingstone, Katherine M., Lovegrove, Julie A., Givens, D. Ian, Livingstone, Katherine M., Lovegrove, Julie A., Givens, D. Ian
author_sort livingstone, katherine m.
container_issue 2
container_start_page 193
container_title Nutrition Research Reviews
container_volume 25
description <jats:p>With the substantial economic and social burden of CVD, the need to modify diet and lifestyle factors to reduce risk has become increasingly important. Milk and dairy products, being one of the main contributors to SFA intake in the UK, are a potential target for dietary SFA reduction. Supplementation of the dairy cow's diet with a source of MUFA or PUFA may have beneficial effects on consumers' CVD risk by partially replacing milk SFA, thus reducing entry of SFA into the food chain. A total of nine chronic human intervention studies have used dairy products, modified through bovine feeding, to establish their effect on CVD risk markers. Of these studies, the majority utilised modified butter as their primary test product and used changes in blood cholesterol concentrations as their main risk marker. Of the eight studies that measured blood cholesterol, four reported a significant reduction in total and LDL-cholesterol (LDL-C) following chronic consumption of modified milk and dairy products. Data from one study suggested that a significant reduction in LDL-C could be achieved in both the healthy and hypercholesterolaemic population. Thus, evidence from these studies suggests that consumption of milk and dairy products with modified fatty acid composition, compared with milk and dairy products of typical milk fat composition, may be beneficial to CVD risk in healthy and hypercholesterolaemic individuals. However, current evidence is insufficient and further work is needed to investigate the complex role of milk and cheese in CVD risk and explore the use of novel markers of CVD risk.</jats:p>
doi_str_mv 10.1017/s095442241200011x
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNy9zMDk1NDQyMjQxMjAwMDExeA
imprint Cambridge University Press (CUP), 2012
imprint_str_mv Cambridge University Press (CUP), 2012
institution DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1
issn 0954-4224, 1475-2700
issn_str_mv 0954-4224, 1475-2700
language English
last_indexed 2024-03-01T17:10:28.961Z
match_str livingstone2012theimpactofsubstitutingsfaindairyproductswithmufaorpufaoncvdriskevidencefromhumaninterventionstudies
mega_collection Cambridge University Press (CUP) (CrossRef)
physical 193-206
publishDate 2012
publishDateSort 2012
publisher Cambridge University Press (CUP)
record_format ai
recordtype ai
series Nutrition Research Reviews
source_id 49
spelling Livingstone, Katherine M. Lovegrove, Julie A. Givens, D. Ian 0954-4224 1475-2700 Cambridge University Press (CUP) Nutrition and Dietetics Medicine (miscellaneous) http://dx.doi.org/10.1017/s095442241200011x <jats:p>With the substantial economic and social burden of CVD, the need to modify diet and lifestyle factors to reduce risk has become increasingly important. Milk and dairy products, being one of the main contributors to SFA intake in the UK, are a potential target for dietary SFA reduction. Supplementation of the dairy cow's diet with a source of MUFA or PUFA may have beneficial effects on consumers' CVD risk by partially replacing milk SFA, thus reducing entry of SFA into the food chain. A total of nine chronic human intervention studies have used dairy products, modified through bovine feeding, to establish their effect on CVD risk markers. Of these studies, the majority utilised modified butter as their primary test product and used changes in blood cholesterol concentrations as their main risk marker. Of the eight studies that measured blood cholesterol, four reported a significant reduction in total and LDL-cholesterol (LDL-C) following chronic consumption of modified milk and dairy products. Data from one study suggested that a significant reduction in LDL-C could be achieved in both the healthy and hypercholesterolaemic population. Thus, evidence from these studies suggests that consumption of milk and dairy products with modified fatty acid composition, compared with milk and dairy products of typical milk fat composition, may be beneficial to CVD risk in healthy and hypercholesterolaemic individuals. However, current evidence is insufficient and further work is needed to investigate the complex role of milk and cheese in CVD risk and explore the use of novel markers of CVD risk.</jats:p> The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies Nutrition Research Reviews
spellingShingle Livingstone, Katherine M., Lovegrove, Julie A., Givens, D. Ian, Nutrition Research Reviews, The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies, Nutrition and Dietetics, Medicine (miscellaneous)
title The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_full The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_fullStr The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_full_unstemmed The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_short The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
title_sort the impact of substituting sfa in dairy products with mufa or pufa on cvd risk: evidence from human intervention studies
title_unstemmed The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: evidence from human intervention studies
topic Nutrition and Dietetics, Medicine (miscellaneous)
url http://dx.doi.org/10.1017/s095442241200011x